All News

JP spins a semi-fictional account of what is wrong with chain drug stores and mail order prescriptions.

According to a recent FDA safety announcement, varenicline may pose an increased risk of cardiovascular events.

Many of the primary care worksite health centers managed by Walgreens Employer Solutions Group have received Medical Home accreditation from the Accreditation Association for Ambulatory Health Care (AAAHC), the company recently announced.

Last month NABP Executive Director Carmen Catizone, MS, RPh, unveiled an action plan to inspect nonresident compounding pharmacies and create a database to share regulatory information about these pharmacies with the state boards of pharmacy nationwide.

Collaboration between pharmacy benefit managers and community pharmacists may improve patient compliance to vital drug regimens.

This year the National Association of Chain Drug Stores (NACDS) is offering a one-of-a-kind business opportunity by combining its three trade shows-the Marketplace Conference, the Pharmacy and Technology Conference, and the Supply Chain & Logistics Conference-into one, Total Store Expo.

In a drug safety communication, FDA has recommended that the bedtime dose of zolpidem, for the treatment of insomnia, be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving.

FDA’s recent approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, under license from Napo Pharmaceuticals), 125-mg delayed-release tablets, the first anti-diarrheal drug for HIV/AIDS patients taking antiretroviral therapy (ART), is a significant step forward in addressing the unmet medical need of people with HIV/AIDS on ART who experience noninfectious diarrhea, which often can lead to reduced treatment compliance.

FDA issued a draft guidance on Jan. 9 to help industry in the development of opioid drug formulations with abuse-deterrent properties, saying it considers development of these products a high public health priority.

Changes in tablet color significantly increase the odds that patients will stop taking their medications, according to a study published online first Dec. 31, 2012, in JAMA Internal Medicine (formerly known as the Archives of Internal Medicine).

FDA announced recently it approved apixaban (Eliquis, Bristol-Myers Squibb and Pfizer) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Distributing naloxone to heroin users may be a cost-effective way to reduce the number of overdose deaths, a new study finds.

A recent study found no increased risk of stillbirth, neonatal death, or postneonatal death in infants born to women who used a selective serotonin reuptake inhibitor (SSRI) prescription during their pregnancies.

The flu is hitting 29 states particularly hard this year, and more people are seeking their healthcare provider, according to a recent report from the Centers for Disease Control and Prevention (CDC).

The American Academy of Pediatrics (AAP) has published a policy statement to provide pediatricians with recommendations for assessing and treating Clostridium difficile infections (CDI) in children.

Governor Deval Patrick of Massachusetts filed legislation on Jan. 4, to reform the state Board of Pharmacy and strengthen oversight of the compounding pharmacy industry in the state.

Retail pharmacy, at least the version created by major drug chains, is bad for your patients' health. That's the charge by long-time community pharmacist Dennis Miller, RPh, in a new book.

The American Academy of Pediatrics has announced its endorsement of the World Health Organization's (WHO) recommendation that thimerosal not be banned from vaccines.

Vitamin D deficiency may increase risk for developing autism, a researcher suggests.William Grant, Ph.D., Sunlight, Nutrition, and Health Research Center, San Francisco, Calif., and John Cannell, M.D., Vitamin D Council, San Luis Obispo, Calif., found that children ages 6 to 17 years old who lived in states with lower solar UVB doses during the summer and fall were more likely to be diagnosed with autism than those children who lived in states with higher solar UVB doses.

The FDA has warned more than 350 medical practices that they may have received counterfeit, contaminated or ineffective medications.

The use of aspirin, statins and lifestyle changes prior to elective peripheral vascular intervention for peripheral arterial disease (PAD) may reduce the risk for repeat procedures within six months, according to researchers. However, about half of patients failed to receive this therapy, the researchers found.

Oseltamivir (Tamiflu) can now be used to treat children who are 2 weeks of age and older, according to an FDA press release.